shares
-
Financial
Assure Holdings Corp. Announces Pricing of $6 Million Underwritten Public Offering
DENVER, May 12, 2023 (GLOBE NEWSWIRE) — Assure Holdings Corp. (NASDAQ: IONM) (“Assure Holdings” or the “Company”), a provider of…
Read More » -
Safe Group-Effective date of the reverse split and first listing of the new consolidated shares
Completion of the reverse stock split and commencement of trading in the shares resulting from the reverse stock splitAdjustment of…
Read More » -
Financial
Paragon 28, Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
February 17, 2023 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon”), a leading medical device company exclusively focused on the…
Read More » -
Financial
Stryker declares a $0.75 per share quarterly dividend
Kalamazoo Michigan,, Feb. 09, 2023 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly…
Read More » -
Financial
Paragon 28, Inc. Announces Proposed Public Offering of Common Stock
January 25, 2023 ENGLEWOOD, Colo.–(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA) (“Paragon”), a leading medical device company exclusively focused on…
Read More » -
Financial
PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company
SALT LAKE CITY, Dec. 27, 2022 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials (the “Company”), today…
Read More » -
Financial
InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
October 7, 2022 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with…
Read More » -
Financial
Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic
The acquisition will result in the business combination of Bone Therapeutics and Medsenic to create BioSenic, a speciality biopharma company…
Read More » -
Financial
Ortho Regenerative Technologies Closes Oversubscribed Non-Brokered Private Placement for $3.2 Million
Proceeds to be used to accelerate the ORTHO-R Phase I/II US Clinical trial for rotator cuff tear repairInsiders contribute approximately $560,000 MONTREAL, April…
Read More » -
Financial
Ortho Regenerative Technologies Announces $3 Million Non-Brokered Private Placement of Units
MONTREAL, Feb. 11, 2022 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) (“Ortho” or the “Company“), a clinical-stage orthobiologics company focused on…
Read More » -
Financial
Zimmer Biomet Announces Expected Completion Date of March 1, 2022 for Spinoff of ZimVie
– “When-issued” trading of ZimVie common stock expected to begin on February 14, 2022 – Record date for distribution of…
Read More » -
Financial
Stryker commences tender offer for all outstanding shares of common stock of Vocera Communications
Kalamazoo, Michigan, Jan. 25, 2022 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) today announced that it is commencing, through a wholly owned…
Read More » -
Financial
Stryker announces definitive agreement to acquire Vocera Communications
Kalamazoo, Michigan, Jan. 06, 2022 (GLOBE NEWSWIRE) — Stryker (NYSE: SYK) announced today a definitive merger agreement to acquire all…
Read More » -
Financial
Stryker declares a $0.695 per share quarterly dividend
Kalamazoo, Michigan, Dec. 09, 2021 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly…
Read More » -
Financial
NuVasive (NUVA) Up on Rumors of Takeover by Globus Medical
Zacks Equity Research – Zacks / November 16, 2021 NuVasive, Inc. NUVA shares gained nearly 5% to reach $58.90 yesterday, after a takeover…
Read More »